CytoReason and Summit Pharmaceuticals International Forge Commercial Alliance To Bring CytoReason’s Machine Learning Model of the Immune System for Drug Discovery & Development To Japanese Drug Makers

We will set up a booth at CPhI Japan 2019

Sumitomo Corporation Group Statement for UK Modern Slavery Act 2015 (FY 2017 Statement)

Sumitomo Corporation Group Statement for UK Modern Slavery Act 2015 (FY 2016 Statement)

Our head office in Tokyo will move as of May 22, 2017

We will set up a booth at CPhI Japan 2017

Successful Identification of Metabolite Differences in Urine between Healthy, Breast Cancer and Colorectal Cancer Groups

TRANSFER OF BUSINESS FROM SUMMIT PHARMACEUTICALS INTERNATIONAL TO SUMITOMO CORPORATION

We will set up a booth at CPhI Japan 2016

We exhibited at CPhI Worldwide 2015

We will set up a booth at CPhI Worldwide 2015

Sumitomo Group to Advance into Cosmetic Materials Business in Europe -Acquiring Cosmetic Materials Business from Kyowa Hakko Europe GmbH-